Tucatinib 937263-43-9
1 Inquiries
937263-43-9
Pharmaceutical Grade
99%
Zison
foil bag
2023-03-31
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine
Other Name:4,6-Quinazolinediamine,N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-;N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine;ARRY 380;ONT 380;Tucatinib;Tukysa
CAS No.:937263-43-9
Molecular Formula:C26H24N8O2
InChIKeys:InChIKey=SDEAXTCZPQIFQM-UHFFFAOYSA-N
Molecular Weight:480.52116
Exact Mass:480.52
UNII:234248D0HH
NCI Thesaurus Code:C77896
ATC Code:L01|L - Antineoplastic and immunomodulating agents
Categories:
Characteristics-
PSA:
111
XLogP3:4
Density:1.4±0.1 g/cm3
Melting Point:230
Refractive Index:1.729
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Location:
Room 410, Building 9, No. 2566, Century Avenue, Jinan, 250104, China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
Certifications:
business license,ISO
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
South Korea
Tucatinib 937263-43-9
10 G Sep 17, 2025 Post an enquiry for this product
